This mechanism is also responsible for the diminished resistance to anti-PD-1 immunotherapy in melanoma, suggesting LSD1 as a promising immunotherapy target.171 It seems that H3K9 methylation regulated by SETDB1, LSD1, and JMJD2C plays contrary roles in melanoma carcinogenesis and development respectively. This evidence concerns the gene SETDB1 and melanoma.